Information for ligand CP0

sorry, the picture is missed

sdf, pdb, mol, mol2


Ligand Name: (4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl 1,4'-bipiperidine-1'-carboxylate


Synonyms

1 Irinotecan
2 Cpt-11
3 Irinotecanum
4 (+)-irinotecan
5 Irinotecan lactone
6 Hsdb 7607
7 Irinotecan mylan
8 Irinophore c
9 (4s)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate

Chemical Component Summary

Formula "C33 H38 N4 O6"
Molecular Weight 586.678
SMILES CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(OC(=O)N6CCC(CC6)N7CCCCC7)cc15)[C@@](O)(CC)C(=O)OC4
InchI InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1
InChIkey UWKQSNNFCGGAFS-XIFFEERXSA-N
DrugBank Reference DB00762
ChEBI Reference 80630
PubChem Reference 60838
FDA approved drug yes

Reference

  • Wei et al, Q-BioLiP: A Comprehensive Resource for Quaternary Structure-based Protein–ligand InteractionsGenomics, Proteomics & Bioinformatics, 22(1), qzae001, 2024. (PDF)